BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 17241177)

  • 1. A dendritic cell-based vaccine for treating HIV infection: background and preliminary results.
    Andrieu JM; Lu W
    J Intern Med; 2007 Feb; 261(2):123-31. PubMed ID: 17241177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic dendritic-cell vaccine for simian AIDS.
    Lu W; Wu X; Lu Y; Guo W; Andrieu JM
    Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection.
    Lu W; Arraes LC; Ferreira WT; Andrieu JM
    Nat Med; 2004 Dec; 10(12):1359-65. PubMed ID: 15568033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of virus-specific T cell responses by dendritic cell vaccination in the chronic phase of simian AIDS models.
    Kato M; Igarashi H; Takeda A; Horie S; Higashihara E; Matano T
    Jpn J Infect Dis; 2004 Oct; 57(5):220-3. PubMed ID: 15507782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection.
    García F; Lejeune M; Climent N; Gil C; Alcamí J; Morente V; Alós L; Ruiz A; Setoain J; Fumero E; Castro P; López A; Cruceta A; Piera C; Florence E; Pereira A; Libois A; González N; Guilá M; Caballero M; Lomeña F; Joseph J; Miró JM; Pumarola T; Plana M; Gatell JM; Gallart T
    J Infect Dis; 2005 May; 191(10):1680-5. PubMed ID: 15838795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag.
    Melhem NM; Liu XD; Boczkowski D; Gilboa E; Barratt-Boyes SM
    Eur J Immunol; 2007 Aug; 37(8):2164-73. PubMed ID: 17615585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
    Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus 5- and 35-based immunotherapy enhances the strength but not breadth or quality of immunity during chronic SIV infection.
    Soloff AC; Liu X; Gao W; Day RD; Gambotto A; Barratt-Boyes SM
    Eur J Immunol; 2009 Sep; 39(9):2437-49. PubMed ID: 19670380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
    Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
    J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of SIV-lipopeptide immunizations administered by the intradermal route in their ability to induce antigen specific T-cell responses in rhesus macaques.
    Coutsinos Z; Villefroy P; Gras-Masse H; Guillet JG; Bourgault-Villada I
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):357-66. PubMed ID: 15708309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response.
    Boyer JD; Kumar S; Robinson T; Parkinson R; Wu L; Lewis M; Weiner DB
    J Med Primatol; 2006 Aug; 35(4-5):202-9. PubMed ID: 16872283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial.
    Ide F; Nakamura T; Tomizawa M; Kawana-Tachikawa A; Odawara T; Hosoya N; Iwamoto A
    J Med Virol; 2006 Jun; 78(6):711-8. PubMed ID: 16628588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC-I non-restricted cytotoxic activity in Macaca sylvana experimentally inoculated with HIV2 and SIV/mac.
    Charaf B; Sanhadji K; Sekkat S; Farouqui B; Touraine JL; Benslimane A
    Thymus; 1993 Aug; 22(1):1-12. PubMed ID: 7905683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postinfection passive transfer of KD-247 protects against simian/human immunodeficiency virus-induced CD4+ T-cell loss in macaque lymphoid tissue.
    Murakami T; Eda Y; Nakasone T; Ami Y; Someya K; Yoshino N; Kaizu M; Izumi Y; Matsui H; Shinohara K; Yamamoto N; Honda M
    AIDS; 2009 Jul; 23(12):1485-94. PubMed ID: 19528788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro human immunodeficiency virus eradication by autologous CD8(+) T cells expanded with inactivated-virus-pulsed dendritic cells.
    Lu W; Andrieu JM
    J Virol; 2001 Oct; 75(19):8949-56. PubMed ID: 11533158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.
    Lapenta C; Santini SM; Logozzi M; Spada M; Andreotti M; Di Pucchio T; Parlato S; Belardelli F
    J Exp Med; 2003 Jul; 198(2):361-7. PubMed ID: 12874266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte derived dendritic cells from HIV-1 infected individuals partially reconstitute CD4 T-cell responses.
    Newton PJ; Weller IV; Williams IG; Miller RF; Copas A; Tedder RS; Katz DR; Chain BM
    AIDS; 2006 Jan; 20(2):171-80. PubMed ID: 16511409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
    Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
    Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
    Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.